The Big Tech Rally — Market Insights (Q2 2023)

Big Tech leads the way

The Nasdaq 100 index was down more than 32% in 2022, and in a stunning reversal, in just six months, it had recouped all the losses from last year as it gained more than 39% in the first half of 2023. 

How did this happen? It all started with two letters — AI. As ChatGPT hit mainstream media, stocks that were deemed to benefit the most from developments in artificial intelligence started to see a pop in share price as investors raced to gain exposure to this megatrend.

The S&P 500 index too enjoyed a healthy rebound as it went up by close to 17% in the first half of 2023, nearly recouping its losses from 2022 (-18%). The disconnect and the large discrepancy in performance between the two indices mostly came from the weights in the seven mega technology stocks — Apple, Amazon, Alphabet (Google), Meta (Facebook), Microsoft, Nvidia, and Tesla. 

As of 13 July 2023, these top seven mega-cap tech stocks made up about 28% of the S&P 500 index and 60% of the Nasdaq 100 index. (The calculations were made prior to the index’s special rebalancing taking effect before market open on 24 July 2023.) 

Can this narrow rally be sustained? Will it broaden out to the rest of the market? Our view remains that this has always been hard to predict. Uncertainty lies ahead in the second half of 2023. Investors will assess how central banks balance between a growth pullback and cooling inflation. Recession risks seem to be receding, and a soft landing in the economy is starting to look more possible. However, concerns persist on how inflation coming from wages and services is still sticky. 

In the US, the Federal Reserve’s 2% inflation target remains, and eyes are on the Fed to see how they navigate the “Goldilocks” situation. If they read inflation wrong and tighten too much or too quickly, they may trigger a sharp economic downturn as businesses get overwhelmed by much greater financing costs — or in other words, the cost of borrowing — and consumers pause on spending.

We don’t know how much more the Fed and other central banks will raise rates in the second half of 2023. When it comes to the Fed, the markets seem to have priced in one or two more rate hikes. Because of this uncertainty, it is advisable to stay invested in a globally diversified portfolio, with fixed income exposure along different parts of the yield curve and sectors, as well as equity exposure in both developed and emerging markets. 

For those interested in getting exposure to the AI theme, they can consider a portfolio that places focused, strategic allocations on core technology sectors, as well as non-traditional technology sectors. These include companies that perhaps do not originate from the industry, but will leverage technology to enhance their competitive advantage within their specific sectors and create long-term shareholder value.

Q2 2023 market update

Global equity market 

In the equities space, the global equity markets, as represented by the MSCI All Country World Index (ACWI), were up by about 6.2% in Q2 2023 in US dollar (USD) terms. ‍

‍Growth stocks, in general, outperformed value by a wide margin of more than 600 basis points. The difference was even more stark when comparing the performance year-to-date.The MSCI ACWI Growth Index returned 24.3% versus a 4.3% return for MSCI ACWI Value Index in H1 2023, largely driven by US technology stocks. In a repeat of Q1 2023, large-cap stocks again outperformed small caps in Q2 2023.

The US as a market did very well in Q2, even as its performance was second to Japan. The rest of the developed markets turned in a lacklustre quarter but still outperformed the emerging markets which were almost flat for the quarter. China’s decline of nearly 10% weighed heavily on the performance of the overall emerging markets (EM) region. In a surprising twist, EM value stocks outperformed EM growth stocks by about 3%.

Global fixed income market

On the fixed-income front, as volatility receded in Q2 2023 and as the prospect of a soft landing increased, bond yields rose again. 

Credit was one of the strongest performing sectors for the quarter. High-yield (HY) outperformed investment-grade (IG) corporate, and investment-grade (IG) corporate in turn outperformed Treasuries. Inflation-linked bonds, known also as linkers, were the worst performers, partly due to their longer duration and maturity. 

Duration dragged on fixed-income performance as longer-dated bonds generally underperformed shorter-maturity bonds. Emerging-market debt was also one of the top performers in Q2.

Commodities and gold

The S&P GSCI Index posted a negative return of 2.7% for the second quarter of 2023, with energy and industrial metals leading the decline. The industrial metals sector was down about 9.1%, and energy retracted 11.6%. Within industrial metals, zinc was the worst performer, with a return of -17.3%. Gold was mildly negative at -2.5% while the agriculture and livestock sector eked out a positive return of 0.9%.

<divider><divider>

To get started with Endowus HK, click here.

Read more: 

• Endowus HK model portfolios Q2 2023 performance review
• Introducing Endowus model portfolios — curated with Best-In-Class Funds for core-satellite strategies
• Why invest through Endowus
• Introducing the Endowus HK team
• Choosing Endowus when investing in Hong Kong

<divider><divider>‍

Risk Warnings

Investment involves risk. Past performance is not an indicator nor a guarantee of future performance or returns. Projected performance or returns is not guaranteed to materialise. The value of investments and the income from them can go down as well as up, and you may not get the full amount you invested. Rates of exchange may cause the value of investments to go up or down. Individual stock performance does not represent the return of a fund.

General risk warnings relating to collective investment schemes 

Before making an investment decision, you are reminded to refer to the relevant prospectus/ offering document for specific risk considerations and related fees and charges. Funds are not a bank deposit and not capital guaranteed, and is subject to investment risks, including the possible loss of the principal amount invested. Some of the funds also involve derivatives. Do not invest in them unless you fully understand and are willing to assume the risks associated with them.

Complex Products

Some of the funds contained in this article are complex products and investors should exercise caution when investing in these products. Though these products have been authorised by the SFC, authorization does not imply official recommendation. SFC authorization is not a recommendation or endorsement of a product nor does it guarantee the commercial merits of a product or its performance.

Opinions

Whilst Endowus HK Limited (“Endowus”) has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies or typographical errors.  Any forward-looking statements, prediction, projection or forecast on the economy, stock market, bond market or economic trends of the markets contained in this material are subject to market influences and contingent upon matters outside the control of Endowus HK Limited (“Endowus”) and therefore may not be realised in the future. Further, any opinion or estimate is made on a general basis and subject to change without notice. In presenting the information above, none of Endowus HK Limited, its affiliates, directors, employees, representatives or agents have given any consideration to, nor have made any investigation of the objective, financial situation or particular need of any user, reader, any specific person or group of persons. Therefore, no representation is made as to the completeness and adequacy of the information to make an informed decision. You should carefully consider whether any investment views and products/ services are appropriate in view of your investment experience, objectives, financial resources and relevant circumstances. You may also wish to seek financial advice through a financial advisor or the Endowus platform and independent legal, accounting, regulatory or tax advice, as appropriate.

No invitation or solicitation

Nothing contained in this article should be construed as a solicitation, an offer to buy or sale, or recommendation, to acquire or dispose of any security, commodity, investment or to engage in any other transaction in any jurisdiction in which such solicitation, offer to buy or sale would be unlawful under the securities laws in such jurisdiction. No information included in this article is to be construed as investment advice or as a recommendation or a representation about the suitability or appropriateness of any advisory product or service; or an offer to buy or sell, or the solicitation of an offer to buy or sell, any security, financial product, or instrument; or to participate in any particular trading strategy. Investors should seek independent financial and tax advice before making any investment decision.

Product Risk Rating: Please note that any product risk rating (the “PRR”) provided by us is an internal rating assigned based on our product risk assessment model, and is for your reference only. The PRR is subject to change from time to time. The PRR does not take into account your individual circumstances, objectives or needs and should not be regarded as advice or recommendation to purchase, hold or sell any fund or make any other investment decisions. Accordingly, you should not solely rely on the PRR in making your investment decision in the relevant Fund.

This article  has not been reviewed by the Securities and Futures Commission or any regulatory authority in Hong Kong.